You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Personalized Breast Cancer Risk Assessment Study

This new $15.2-million project is studying how personalized risk assessment, including genetic testing, may help lead to the prevention and early detection of breast cancer.

Researchers will study a large cohort of women ages 40 to 69 years to calculate their risk level and provide them with information to make an informed choice about breast screening.

Background

Breast cancer is the most common cancer and second leading cause of cancer death in Canadian women. Women face a 1 in 8 chance of developing breast cancer in their lifetime. Current breast screening recommendations are based primarily on age. Screening also tends to use a one-size-fits-all approach.

Benefits of Personalized Risk Assessment

Personalized risk assessment using a combination of genomic profiling and other breast cancer risk factors would:

  • allow tailored prevention and screening recommendations based on individual risk to improve the balance of benefits and harms
  • enable earlier detection and treatment of breast cancer, providing health and socio-economic benefits

Participating Research Organizations

The study is being conducted by researchers associated with the following organizations:

  • CCO/Cancer Care Ontario
  • Princess Margaret Cancer Centre/University Health Network
  • Sinai Health System
  • Sunnybrook Health Sciences Centre
  • Institute for Clinical Evaluative Sciences
  • Moffitt Cancer Centre
  • National Cancer Institute
  • Queensland Institute of Medical Research
  • Universities of Toronto, Ottawa, Laval, McGill, Utah, Harvard, Cambridge, College London, Manchester, Leiden, Radboud and Cologne

Funding

This study is funded by the Genome Canada Large Scale Applied Research Project Competition in partnership with the Canadian Institutes of Health Research.

The following organizations have provided co-funding:

  • Ontario Research Fund
  • Génome Québec
  • Québec Ministry of Economic, Science and Innovation
  • CHU de Québec Foundation
  • CHU de Québec – Université Laval Research Center
  • Québec Breast Cancer Foundation

For More Information

If you have specific questions about the Personalized Breast Cancer Risk Assessment Study, please get in touch with us:

Phone: 416-217-1226
Toll-free: 1-833-781-6046
Email: PERSPECTIVEstudy@cancercare.on.ca

Resources for Healthcare Providers

Information for Healthcare Providers - Download this information sheet to help answer questions from your patients invited to take part in the PERSPECTIVE study.

Understanding Your Breast Cancer Risk Assessment - We send this 6-page booklet to women participating in the PERSPECTIVE study when they receive their risk letters (see sample letters).

Sample Letters

We send study participants a letter after their assessment to let them know their 10-year breast cancer risk estimate and to propose an action plan based on their level of risk. For details, see these sample letters.

Average Risk Letter
Average or Higher than Average Risk with Family History Letter
Higher Than Average Risk Letter
High Risk Letter